A new AI tool is revolutionizing cancer treatment decisions by analyzing tissue images to predict tumor aggressiveness. This ...

Researchers in a recent breakthrough have identified a better and more advanced way to examine cancer biopsies by using ...

In most solid tumors, high numbers of regulatory T (Treg) cells are associated with poorer outcomes because they dampen the ...

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced the successful ...

The tool scans digital images of the same cancer tissue samples that pathologists use and can tell how fast the cancer is ...

A new study from Memorial Sloan Kettering Cancer Center finds that in colorectal cancer, not all regulatory T cells are ...

RASolute 304 is anticipated to enroll approximately 500 patients with PDAC harboring oncogenic RAS mutations who have undergone resection and completed perioperative chemotherapy. The trial will ...

A blood test could help doctors decide which patients with colon cancer should receive anti-inflammatory medication along ...

The clinical and biological features proposed here in conjunction with ML can improve the interpretation of CRC mechanisms and predict patient ...

Siddhartha Mukherjee, oncologist and author of “The Emperor of All Maladies,” asks: What if we change what a tumor can eat?

Older Americans with metastatic breast, colorectal, lung, or prostate cancer are spending an increasing amount of time in the ...

Canadian biotech Oncolytics Biotech (Nasdaq: ONCY) has reported encouraging clinical and translational data for its oncolytic ...